MMR vaccination: Are we doing enough?

Vaccines: Children and Practice

Volumn 1, Issue 2, 1998, Pages 5-9

  White, Joanne M ^a   Ramsay, Mary E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUTISM; CHILD; CROHN DISEASE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; IMMUNIZATION; MASS MEDIUM; MEASLES; MUMPS; PRIORITY JOURNAL; RUBELLA; UNITED KINGDOM; VACCINATION;

EID: 0009829777     PISSN: 14606887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Communicable Diseases Statistics (Series MB2). Office for National Statistics, UK
2. Vaccination and Immunisation Summary Tables. Department of Health, Statistics Division, UK
3. Miller CL. MMR vaccine: a new initiative. Practitioner 1989; 233: 63-6
4. Miller E, Waight PA, Vurdein JE, et al. Rubella surveillance to December 1990: a joint report from the PHLS and National Congenital Rubella Surveillance Programme. CDR (Lond Engl Rev) 1991; 1: R33-7
5. Miller CL, Miller E, Waight PA. Rubella susceptibility and the continuing risk of infection in pregnancy, BMJ 1989; 294: 1277-8
6. Department of Health, Welsh Office, Scottish Office Department of Health, DHSS (Northern Ireland). Immunisation against infectious disease - 1996 Edward Jenner bicentenary edition. London: HMSO, 1996
7. Cutts FT, Markowitz LE. Successes and failures in measles control. J Infect Dis 1994; 170: S1-10
8. Ramsay M, Gay N, Miller E, et al. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev 1994; 4: R141-6
9. Gay N, Ramsay M, Cohen B, et al. The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun Dis Rep CDR Rev 1997;7: R17-21
10. Miller E, Waight PA, Gay N, et al. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 1997; 7: R26-32
11. Gay N, Miller E, Hesketh L, et al. Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev 1997; 7: R21-6
12. Wakefield AJ, Pittilo RM, Sim R. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39: 345-53
13. Ekbom A, Daszak P, Kraaz W, et al. Crohn's disease after in-utero measles virus exposure. Lancet 1996; 348: 515-17
14. Thompson NP, Montgomery SM, Pounder RE, et al. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345:1071-4
15. Jones P, Fine P, Piracha S. Crohn's disease and measles. Lancet 1997; 249: 473
16. Nielsen LLW, Nielsen NM, Melbye M, et al. Exposure to measles in utero and Crohn's disease: a Danish register study. BMJ 1998; 316: 196-7
17. Feeney M, Clegg A, Winwood P, et al. A case control study of measles vaccination and inflammatory bowel disease. Lancet 1997; 350: 764-6
18. World Health Organization. Expanded programme on immunization (EPI) - association between measles infection and the occurrence of chronic inflammatory bowel disease. Wky Epidemiol Rec 1998; 73: 33-40
19. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41
20. Murch S, Thompson M, Walker Smith J. Autism, inflammatory bowel disease, and MMR vaccine [letter]. Lancet 1998; 351: 908
21. Chief Medical Officer, Measles, MMR vaccine, Crohn's disease and autism. CMO letter PL/CMO/98/2, 1998
22. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet 1998; 351: 611-12
23. Peltola H, Patja A, Leinikki P, et al. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351: 1327-8
24. Government Statistics Service. Vaccination and immunisation. Summary information for 1996-97, England. London: Department of Health Statistics Division 2B, 1997
25. CDSC. COVER/Körner: October to December 1997. Commun Dis Rep CDR Wkly 1998; 8: 116
26. Begg N, Ramsay M, White J, et al. Media dents confidence in MMR vaccine. BMJ 1998; 316: 561
27. Peckham C, Bedford H, Senturia Y, et al. The Peckham Report. National immunisation study: factors influencing immunisation uptake in childhood. Horsham, UK: Action Research for the Crippled Child, 1989
28. Crawley H. How we reassure parents on MMR. Pulse 1998; April 25: 89-90
29. Department of Health and Social Security, Welsh Office, Scottish Home and Health Department. Immunisation against infectious disease, London: HMSO, 1988
30. Begg NT, White JM. A survey of pre-school vaccination programmes in England and Wales. Community Med 1988; 10: 344-50
31. Begg NT, Gill ON, White JM. COVER (Cover of Vaccination Evaluated Rapidly): description of the England and Wales scheme. Public Health 1989; 103: 81-9
32. Cangarosa EJ, Galaska AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351: 356-61
33. Commun Dis Rep CDR Wkly 1998; 8: 93